Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1e2j | THM | Thymidine kinase |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1e2j | THM | Thymidine kinase | / | 1.000 | |
| 1e2n | RCA | Thymidine kinase | / | 0.559 | |
| 4ivq | I43 | Thymidine kinase | / | 0.549 | |
| 4ivr | N50 | Thymidine kinase | / | 0.537 | |
| 4jbx | SK7 | Thymidine kinase | / | 0.492 | |
| 1e2l | TMC | Thymidine kinase | / | 0.491 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.488 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.486 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.485 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.484 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.479 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.477 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.476 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.474 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.474 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.471 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.467 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.465 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.462 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.458 | |
| 3d2d | REN | Reticuline oxidase | 1.21.3.3 | 0.455 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.455 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
| 3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
| 1ne6 | SP1 | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.453 | |
| 3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.453 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.452 | |
| 3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.452 | |
| 2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 4ug2 | NGI | Adenosine receptor A2a | / | 0.451 | |
| 2yvw | EPU | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.450 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.450 | |
| 2vqs | BVD | Deoxynucleoside kinase | / | 0.447 | |
| 2fjd | SFD | Adenylylsulfate reductase, subunit A (AprA) | / | 0.446 | |
| 4l23 | X6K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.446 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
| 1zdw | FLV | Prenyltransferase | / | 0.444 | |
| 2fjb | SFD | Adenylylsulfate reductase, subunit A (AprA) | / | 0.443 | |
| 3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.442 | |
| 3gnv | XNZ | Genome polyprotein | 2.7.7.48 | 0.442 |